Guangzheng Eye Hospital Group Co.,Ltd. (SHE:002524)
China · Delayed Price · Currency is CNY 4.030
+0.030 (0.75%)
Aug 21, 2026, 3:04 PM CST
SHE:002524 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| 2,061 | 2,107 | 1,873 | 3,315 | 3,651 | 4,698 | |
Market Cap Growth | -14.78% | 12.50% | -43.50% | -9.20% | -22.29% | -36.74% |
Enterprise Value | 2,750 | 2,864 | 2,679 | 4,130 | 4,383 | 5,395 |
Last Close Price | 4.03 | 4.12 | 3.64 | 6.45 | 7.14 | 9.17 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 358.19 | - | 127.23 |
Forward PE | - | 43.56 | 43.56 | 43.56 | 43.56 | 43.56 |
PS Ratio | 2.46 | 2.38 | 2.10 | 3.08 | 4.76 | 4.50 |
PB Ratio | 18.38 | 21.05 | 15.97 | 11.60 | 13.29 | 13.76 |
P/FCF Ratio | 19.59 | 22.02 | 43.24 | 214.13 | 43.67 | 50.57 |
P/OCF Ratio | 16.33 | 16.89 | 27.12 | 85.21 | 29.37 | 32.32 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.28 | 3.24 | 3.00 | 3.84 | 5.71 | 5.17 |
EV/EBITDA Ratio | 29.46 | 48.04 | 100.14 | 56.48 | - | 98.06 |
EV/EBIT Ratio | 81.67 | 100.14 | - | 112.14 | - | 900.40 |
EV/FCF Ratio | 26.14 | 29.93 | 61.85 | 266.78 | 52.42 | 58.06 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 6.60 | 7.59 | 7.16 | 3.11 | 3.01 | 2.33 |
Debt / EBITDA Ratio | 7.92 | 6.34 | 9.38 | 6.49 | 122.57 | 7.07 |
Debt / FCF Ratio | 7.03 | 7.94 | 19.40 | 57.50 | 9.90 | 8.55 |
Net Debt / Equity Ratio | 6.15 | 7.11 | 6.59 | 2.80 | 2.77 | 2.07 |
Net Debt / EBITDA Ratio | 10.97 | 11.94 | 28.87 | 10.93 | -14.41 | 12.82 |
Net Debt / FCF Ratio | 6.56 | 7.44 | 17.83 | 51.62 | 9.11 | 7.59 |
Asset Turnover | 0.71 | 0.73 | 0.64 | 0.69 | 0.45 | 0.63 |
Inventory Turnover | 17.93 | 20.85 | 20.24 | 16.10 | 10.44 | 11.49 |
Quick Ratio | 0.30 | 0.29 | 0.32 | 0.36 | 0.24 | 0.27 |
Current Ratio | 0.36 | 0.35 | 0.39 | 0.42 | 0.33 | 0.35 |
Return on Equity (ROE) | -2.49% | -18.10% | -86.79% | 3.48% | -25.25% | 10.75% |
Return on Assets (ROA) | 1.77% | 1.47% | -0.27% | 1.48% | -3.44% | 0.23% |
Return on Invested Capital (ROIC) | -0.60% | 3.36% | -0.62% | 3.47% | -8.95% | 0.57% |
Return on Capital Employed (ROCE) | 6.90% | 6.30% | -1.10% | 4.60% | -12.50% | 0.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Earnings Yield | -0.15% | -0.92% | -9.32% | 0.28% | -2.14% | 0.79% |
FCF Yield | 5.10% | 4.54% | 2.31% | 0.47% | 2.29% | 1.98% |
Payout Ratio | - | - | - | - | - | 44.74% |
Buyback Yield / Dilution | - | 5.11% | -11.01% | 11.26% | -0.81% | -0.17% |